• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在低级别神经胶质瘤中, 的低表达与良好的预后和对放射/药物治疗的敏感性相关。

Low expression of is associated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma.

机构信息

Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Neurol Res. 2020 Jun;42(6):522-527. doi: 10.1080/01616412.2020.1748323. Epub 2020 Apr 3.

DOI:10.1080/01616412.2020.1748323
PMID:32245342
Abstract

: is overexpressed in multiple cancers including malignant glioma and contributes to different cellular processes. However, little attention has been paid to the lower grade glioma (LGG).: Cox coefficients were examined to compare expression among different tumors types using OncoLnc. The UCSC Xena browser was used to generate Kaplan-Meier survival curves and explore the association between expression and overall survival (OS) in TCGA-LGG and subgroups.: expression in LGG was ranked first among 21 different cancers. LGG with lower expression had longer OS ( < 0.001). The astrocytoma group had the highest expression and shortest OS, followed by oligoastrocytoma and oligodendroglioma ( < 0.05). The 1p19q co-deletion or mutation subgroups had lower expression and longer OS ( < 0.001). Compared with the corresponding groups, LGG with lower expression had longer OS than the following groups: astrocytoma, oligodendroglioma, with/without 1p19q co-deletion, with mutation, with radiation, and with pharmaceutical therapy ( < 0.05).: is a prognostic marker in LGG and subgroups.

摘要

在包括恶性神经胶质瘤在内的多种癌症中过度表达,并有助于多种细胞过程。然而,低级别神经胶质瘤(LGG)很少受到关注。

使用 OncoLnc 检查 Cox 系数以比较不同肿瘤类型中的表达。使用 UCSC Xena 浏览器生成 Kaplan-Meier 生存曲线,并探索 TCGA-LGG 和亚组中表达与总生存期(OS)之间的关联。

在 21 种不同癌症中,LGG 中的表达排名第一。表达较低的 LGG 具有更长的 OS(<0.001)。星形细胞瘤组表达最高,OS 最短,其次是少突星形细胞瘤和少突胶质细胞瘤(<0.05)。1p19q 共缺失或突变亚组的表达较低,OS 较长(<0.001)。与相应的组相比,表达较低的 LGG 具有比以下组更长的 OS:星形细胞瘤、少突胶质细胞瘤、具有/不具有 1p19q 共缺失、具有突变、具有放射治疗和具有药物治疗(<0.05)。

是 LGG 和亚组的预后标志物。

相似文献

1
Low expression of is associated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma.在低级别神经胶质瘤中, 的低表达与良好的预后和对放射/药物治疗的敏感性相关。
Neurol Res. 2020 Jun;42(6):522-527. doi: 10.1080/01616412.2020.1748323. Epub 2020 Apr 3.
2
Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion.EYA4 在 IDH1 突变伴 1p19q 共缺失的低级别胶质瘤中的预后作用。
World Neurosurg. 2021 May;149:e1174-e1179. doi: 10.1016/j.wneu.2020.07.094. Epub 2021 Feb 23.
3
Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.作为低级别胶质瘤潜在预后标志物的Engrailed 1过表达
PeerJ. 2019 Sep 16;7:e7414. doi: 10.7717/peerj.7414. eCollection 2019.
4
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.SHOX2是预测世界卫生组织II-III级弥漫性胶质瘤患者生存的有效独立生物标志物。
EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.
5
Aquaporin-4 as a New Potential Molecular Biomarker for Prognosis of Low-Grade Glioma: Comprehensive Analysis Based on Online Platforms.水通道蛋白 4 作为低级别胶质瘤预后的新潜在分子生物标志物:基于在线平台的综合分析。
World Neurosurg. 2023 Jul;175:e713-e722. doi: 10.1016/j.wneu.2023.04.010. Epub 2023 Apr 8.
6
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.1p19q 共缺失的异柠檬酸脱氢酶突变型脑胶质瘤中鸡卵清蛋白上游启动子转录因子 II 的预后作用。
J Mol Neurosci. 2019 Jun;68(2):234-242. doi: 10.1007/s12031-019-01281-4. Epub 2019 Mar 30.
7
Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.系统筛查发现 GABRD,GABAA 受体亚基基因,是 IDH 野生型弥漫性低级别胶质瘤的预后标志物。
Biomed Pharmacother. 2019 Oct;118:109215. doi: 10.1016/j.biopha.2019.109215. Epub 2019 Aug 23.
8
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.丝氨酸掺入因子 2(SERINC2)表达预测低级别胶质瘤(LGG)的不良预后:来自生物信息学分析的证据。
J Mol Neurosci. 2020 Oct;70(10):1521-1532. doi: 10.1007/s12031-020-01620-w. Epub 2020 Jul 8.
9
FYN as an emerging biological biomarker for prognosis and potential therapeutic target in LGG.FYN作为低级别胶质瘤预后的新兴生物标志物和潜在治疗靶点。
Neurol Res. 2024 Sep;46(9):787-795. doi: 10.1080/01616412.2024.2354620. Epub 2024 May 16.
10
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶(IDH)突变、1p19q共缺失和α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)缺失
Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497.

引用本文的文献

1
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer.FOSL1 是一个关键调节因子,它驱动三阴性乳腺癌中 TCOF1 的表达,该表达受超级增强子调控。
Epigenetics Chromatin. 2024 Nov 10;17(1):34. doi: 10.1186/s13072-024-00559-1.
2
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein.沉默 AHNAK 通过上调 ANXA2 蛋白促进鼻咽癌的进展。
Cell Oncol (Dordr). 2024 Jun;47(3):833-850. doi: 10.1007/s13402-023-00898-3. Epub 2023 Nov 14.
3
Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis.
转录因子 FOSL1 在器官发育和肿瘤发生中的作用。
Int J Mol Sci. 2022 Jan 28;23(3):1521. doi: 10.3390/ijms23031521.
4
Silent FOSL1 Enhances the Radiosensitivity of Glioma Stem Cells by Down-Regulating miR-27a-5p.沉默 FOSL1 通过下调 miR-27a-5p 增强脑肿瘤干细胞的放射敏感性。
Neurochem Res. 2021 Dec;46(12):3222-3246. doi: 10.1007/s11064-021-03427-6. Epub 2021 Aug 21.